Khodabandeh Z, Jamhiri I, Dehghani N, Daneshpazhouh H, Namavar Jahromi B, Dianatpour M, Alaee S
Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Biology, College of Science, Fars Science and Research Branch, Islamic Azad University, Shiraz, Iran.
Iran J Vet Res. 2021 Winter;22(1):40-47. doi: 10.22099/ijvr.2020.38128.5554.
Docetaxel is beneficial in oocyte cryopreservation.
The effect of docetaxel, on the survival, fertilization rate and mRNA expression of apoptosis-related genes of vitrified mature oocytes was investigated.
Mature oocytes were divided into eight experimental groups, including I) control, II) docetaxel, III) docetaxel + cryoprotectant agent 1 (CPA1), IV) docetaxel + CPA2, V) docetaxel + vitrification 1 (Vit1), VI) docetaxel + Vit2, VII) Vit1, and VIII) Vit2. The survival and fertilization rates, and the mRNA expression level of , and as apoptosis-related genes were evaluated.
The survival rates in Vit1, and Vit2 groups were significantly lower than in the control group (P<0.05). The fertilization rates in docetaxel + Vit1, docetaxel + Vit2, Vit1, and Vit2 were significantly lower than the control, docetaxel, and related groups using docetaxel and CPAs. expression was significantly increased in groups which oocytes vitrified. Also, its expression in the Vit2 group increased significantly in comparison to the docetaxel + Vit2 group. The expression of the gene was downregulated in docetaxel + CPA2, docetaxel + Vit2 and Vit2 compared to docetaxel group. The ratio significantly increased in docetaxel + CPA2, docetaxel + Vit1, docetaxel + Vit2, Vit1 and Vit2 groups compared to control, docetaxel and the docetaxel + CPA1 group. expression significantly increased in all six groups in comparison to the control, and docetaxel groups. Its expression significantly increased in the Vit1 and Vit2 groups in comparison with docetaxel + Vit1, and docetaxel + Vit2, respectively.
Docetaxel ameliorates the damages to oocytes during vitrification by altering the expression of apoptosis-related genes and its effects are dependent on the vitrification solution used in cryopreservation of oocytes.
多西他赛对卵母细胞冷冻保存有益。
研究多西他赛对玻璃化成熟卵母细胞的存活率、受精率及凋亡相关基因mRNA表达的影响。
将成熟卵母细胞分为8个实验组,包括:I)对照组;II)多西他赛组;III)多西他赛+冷冻保护剂1(CPA1)组;IV)多西他赛+CPA2组;V)多西他赛+玻璃化液1(Vit1)组;VI)多西他赛+Vit2组;VII)Vit1组;VIII)Vit2组。评估存活率、受精率以及凋亡相关基因、和的mRNA表达水平。
Vit1组和Vit2组的存活率显著低于对照组(P<0.05)。多西他赛+Vit1组、多西他赛+Vit2组、Vit1组和Vit2组的受精率显著低于对照组、多西他赛组以及使用多西他赛和CPA的相关组。在卵母细胞玻璃化的组中,表达显著增加。此外,与多西他赛+Vit2组相比,其在Vit2组中的表达显著增加。与多西他赛组相比,多西他赛+CPA2组、多西他赛+Vit2组和Vit2组中的基因表达下调。与对照组、多西他赛组和多西他赛+CPA1组相比,多西他赛+CPA2组、多西他赛+Vit1组、多西他赛+Vit2组、Vit1组和Vit2组中的比率显著增加。与对照组和多西他赛组相比,所有6组中的表达均显著增加。与多西他赛+Vit1组和多西他赛+Vit2组相比,其在Vit1组和Vit2组中的表达分别显著增加。
多西他赛通过改变凋亡相关基因的表达改善玻璃化过程中对卵母细胞的损伤,其效果取决于卵母细胞冷冻保存中使用的玻璃化溶液。